MeSH tree: D27.505
Glucagon-like peptide 1 receptor agonists (GLP-1RA), commonly used to treat diabetes and weight loss, may have additional mental health benefits, especially for people with bipolar disorder, new Griffith University research ...
Aug 24, 2026
0
13
Madison's Center for Healthy Minds (CHM), along with the UW–Madison Department of Educational Psychology and a multi-university team, has found no evidence that mindfulness-based cognitive therapy (MBCT) increases the risk ...
Aug 21, 2026
0
4
Researchers surveyed 114 sports medicine physicians from 38 countries, covering 93 different sports, to explore their views on athletes' use of GLP-1 drugs. Twelve percent said they were aware of athletes using the medications ...
Aug 20, 2026
0
10
Women who are later diagnosed with endometriosis have a markedly higher use of antidepressant and anxiety medication and are far more often in contact with psychiatric hospital departments than other women. This is not only ...
Aug 20, 2026
0
16
Endocrine disruptors are compounds capable of altering the production, transport, metabolism or action of hormones. They are found in various everyday products, such as plastic containers, the inner linings of cans, food ...
Aug 18, 2026
0
4
A familiar song can bring back a memory from decades ago. A particular smell can recall a person or place. And a frightening memory can trigger a simultaneous emotional and physical response almost instantly. Computers, too, ...
Aug 18, 2026
0
19
Charlotte Touzalin was still a young teenager when she began struggling with weight gain, abnormal periods and unwanted facial hair—the same puzzling symptoms that plagued her mom for decades and that no doctor could piece ...
Aug 16, 2026
0
9
GLP-1 receptor agonists and dual agonists have transformed the treatment of obesity and other metabolic diseases, and a new editorial co-authored by Dr. Steven Heymsfield of LSU's Pennington Biomedical Research Center and ...
Aug 14, 2026
0
1565
Outfitting cells in "invisibility cloaks" may offer an easier, less damaging treatment pathway for people with diabetes undergoing cell therapy, according to researchers at Penn State.
Aug 14, 2026
0
36
A new study led by researchers at The University of Texas MD Anderson Cancer Center has shown that inflammatory arthritis occurring as a side effect of immune checkpoint inhibitors behaves like an immune-memory disease, suggesting ...
Aug 12, 2026
0
81
